Joint Venture8 Sept 2025, 07:21 pm
Morepen Laboratories Subsidiary Executes Joint Venture Agreement with Bimedical FZE
AI Summary
Morepen Medipath Limited, a subsidiary of Morepen Laboratories Ltd, has executed a joint venture agreement with Bimedical FZE to form a joint venture company. The new company will carry on the business of manufacturing, trading, and selling medical devices related products. Morepen Laboratories and Bimedical FZE will contribute in the ratio of 50:50 in the share capital of the proposed JVC. The proposed JVC will be related party of Morepen Laboratories, with the company holding 30% shares indirectly through Morepen Medipath Limited.
Key Highlights
- Morepen Medipath Limited, a subsidiary of Morepen Laboratories Ltd, has executed a joint venture agreement with Bimedical FZE.
- The new joint venture company will carry on the business of manufacturing, trading, and selling medical devices related products.
- Morepen Laboratories and Bimedical FZE will contribute in the ratio of 50:50 in the share capital of the proposed JVC.
- The proposed JVC will be related party of Morepen Laboratories, with the company holding 30% shares indirectly through Morepen Medipath Limited.